Allurion, while battling declining revenues, is targeting the loss in muscle mass seen in patients on GLP-1RA therapy.
Wall Street analysts weigh in on Amazon, Nvidia, Carnival, Seagate Technology Holdings, Netflix, and Affirm Holdings.
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward ...
BofA Securities maintained a Buy rating on Eli Lilly stock (NYSE:LLY), with a price target set at $997.00. With a market capitalization of $706 billion and impressive revenue growth of 27.4% over the ...
STOCKSTOWATCHTODAY BLOG Alphabet has an Nvidia -like business inside it. It could be the most valuable part of the internet search giant. Some investors might not know that Alphabet has an AI chip ...